It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia
- Resource Type
- Article
- Source
- In
Blood Advances February 2024 - Subject
Clinical Trials and Observations Lymphoid Neoplasia - Language
- ISSN
- 2473-9529